Bridge Bio is a biopharmaceutical company based in Palo Alto, CA, focused on developing innovative therapies for rare genetic diseases. The company's research and development efforts aim to address unmet medical needs and improve the lives of patients with these conditions.
With a commitment to advancing precision medicine, Bridge Bio collaborates with leading experts in the field to identify and develop potential treatments that target specific genetic mutations. Through strategic partnerships and a patient-centric approach, the company strives to bring new hope to individuals and families affected by rare diseases.
Generated from their business information